Wellness Products and Servicee News

Curated from leading newswires.

BioLumic Expands Light-Activated Seed Technology into South America Through Key Partnerships

BioLumic Expands Light-Activated Seed Technology into South America Through Key Partnerships

BioLumic, an agricultural biotechnology company specializing in light-activated seed programming, announced the expansion of its Corn xTraits™ Licensing Program into South America. The company has est...

December 8, 2025Read More →
U.S. Annuity Considerations Surge 21.5% in 2023 as Americans Seek Guaranteed Retirement Income

U.S. Annuity Considerations Surge 21.5% in 2023 as Americans Seek Guaranteed Retirement Income

U.S. individual annuity considerations surged by 21.5 percent in 2023, reaching approximately $347.7 billion, according to industry data. This growth reflects a fundamental change in how Americans app...

December 8, 2025Read More →
Kevin Sumlin Launches National Scholarship for Student-Athletes Emphasizing Academic-Athletic Balance

Kevin Sumlin Launches National Scholarship for Student-Athletes Emphasizing Academic-Athletic Balance

Veteran American football coach Kevin Sumlin has announced the establishment of The Kevin Sumlin Scholarship for Student Athletes, a national initiative designed to support undergraduate student-athle...

December 6, 2025Read More →
Byrne Elliott Music Releases 'American Revolution' Composition as Global Tribute to American Independence Era

Byrne Elliott Music Releases 'American Revolution' Composition as Global Tribute to American Independence Era

Byrne Elliott Music has released the worldwide debut of the instrumental composition 'American Revolution,' a work designed to musically transport listeners to the era of the U.S. War of Independence ...

December 6, 2025Read More →
Maximize your thought leadership
Soligenix Positioned to Address Growing Rare Disease Treatment Gap Through Late-Stage Development Programs

Soligenix Positioned to Address Growing Rare Disease Treatment Gap Through Late-Stage Development Programs

Soligenix Inc. has been featured in a BioMedWire editorial examining the increasing prevalence of chronic and rare diseases in aging populations. The editorial addresses a critical healthcare challeng...

December 5, 2025Read More →
CNS Pharmaceuticals CEO Details Focus on Overcoming Blood-Brain Barrier to Treat Deadly Brain Cancer

CNS Pharmaceuticals CEO Details Focus on Overcoming Blood-Brain Barrier to Treat Deadly Brain Cancer

In a recent podcast interview, CNS Pharmaceuticals Inc. CEO John Climaco emphasized the company's intensified focus on developing treatments for glioblastoma multiforme, describing GBM as one of the d...

December 4, 2025Read More →
Oncotelic's Joint Venture Identifies Biomarker Predicting Tumor Sensitivity to Intravenous Everolimus Formulation

Oncotelic's Joint Venture Identifies Biomarker Predicting Tumor Sensitivity to Intravenous Everolimus Formulation

Oncotelic Therapeutics, Inc. announced that its joint venture Sapu Nano has identified a High-RICTOR/Low-RPTOR molecular signature that predicts tumor sensitivity to Sapu003, the company's intravenous...

December 4, 2025Read More →
DesignInspire 2025 Exhibition Opens in Hong Kong with Expanded International Participation

DesignInspire 2025 Exhibition Opens in Hong Kong with Expanded International Participation

The DesignInspire 2025 exhibition opened today at the Hong Kong Convention and Exhibition Centre, running until 6 December with free admission for industry professionals and the public from tomorrow. ...

December 4, 2025Read More →
Extend your brand profile by curating daily news.
Norway's November EV Registrations Reach 97.6%, Nearing Complete Market Transformation

Norway's November EV Registrations Reach 97.6%, Nearing Complete Market Transformation

Norway recorded 19,427 battery-only vehicles out of 19,899 newly registered passenger cars in November, pushing the electric vehicle share to 97.6 percent and producing one of the largest monthly regi...

December 4, 2025Read More →
Artificial Intelligence Becomes Central to Biopharma Industry as Adoption Reaches Critical Mass

Artificial Intelligence Becomes Central to Biopharma Industry as Adoption Reaches Critical Mass

A new report reveals that artificial intelligence has moved from a side topic to a central theme in the biopharma industry, with nearly 50% of companies now heavily utilizing AI technologies. Over the...

December 4, 2025Read More →
Rare Disease Treatments Advance Amid Growing Healthcare System Strain

Rare Disease Treatments Advance Amid Growing Healthcare System Strain

The National Institutes of Health estimates that more than 30 million people nationwide are living with a rare disease, creating a rapidly intensifying challenge for the U.S. healthcare system as popu...

December 4, 2025Read More →
Renewable Energy Sector Faces Critical Workforce Shortage Amid Global Transition

Renewable Energy Sector Faces Critical Workforce Shortage Amid Global Transition

The renewable energy sector is confronting a critical shortage of skilled professionals as the global transition away from fossil fuels accelerates. Companies developing solar, wind, and energy storag...

December 4, 2025Read More →
Maximize your thought leadership
Targeting DNA Repair Pathways Could Expand Cancer Immunotherapy Effectiveness

Targeting DNA Repair Pathways Could Expand Cancer Immunotherapy Effectiveness

A newly published study indicates that cancer immunotherapy could be enhanced by targeting the pathways through which tumor cells repair DNA damage. The research suggests that disrupting these DNA dam...

December 4, 2025Read More →
MelGeek Centauri Series Bridges Gaming and Custom Keyboard Markets with Advanced Technology

MelGeek Centauri Series Bridges Gaming and Custom Keyboard Markets with Advanced Technology

The MelGeek Centauri series represents a significant development in the keyboard market by attempting to bridge the traditional divide between gaming-focused peripherals and enthusiast custom keyboard...

December 4, 2025Read More →
GDCompt to Showcase Intelligent Display and Automation Solutions at AUTOMATE 2026

GDCompt to Showcase Intelligent Display and Automation Solutions at AUTOMATE 2026

Guangdong Computer Intelligent Display Co., Ltd. (GDCompt) will present its newest intelligent display terminals, industrial computers, and embedded systems for automation at the AUTOMATE Exhibition i...

December 4, 2025Read More →
Smart Patch Monitoring System Achieves 100% Accuracy in Pilot Study, Addressing Critical Medication Safety Gap

Smart Patch Monitoring System Achieves 100% Accuracy in Pilot Study, Addressing Critical Medication Safety Gap

A pilot study conducted by Vaaji in collaboration with the Penn Artificial Intelligence and Technology Collaboratory (PennAITech) at the University of Pennsylvania has demonstrated 100% technical accu...

December 4, 2025Read More →
Extend your brand profile by curating daily news.
AdvantaPure Achieves Early Compliance with USP 665 Standard for Pharmaceutical Products

AdvantaPure Achieves Early Compliance with USP 665 Standard for Pharmaceutical Products

AdvantaPure, a division of NewAge Industries, Inc., has announced full compliance with the United States Pharmacopeia (USP) 665 guideline for reporting extractables and leachables data in its plastic ...

December 4, 2025Read More →
Tidbits of Change Foundation Recognizes Youth-Mentor Collaborations with Bursary Awards

Tidbits of Change Foundation Recognizes Youth-Mentor Collaborations with Bursary Awards

Three young Canadians are being recognized by the Tidbits of Change Foundation for partnering with a parent or mentor on inspiring projects and achievements.

December 3, 2025Read More →
Intravenous Everolimus Formulation Shows Reduced Gastrointestinal Exposure in New Pharmacokinetic Data

Intravenous Everolimus Formulation Shows Reduced Gastrointestinal Exposure in New Pharmacokinetic Data

New pharmacokinetic data from Oncotelic Therapeutics, Inc. reveals that its intravenous Deciparticle formulation of everolimus, designated Sapu003, significantly reduces gastrointestinal drug accumula...

December 3, 2025Read More →
Lantern Pharma Reports Positive Phase 1a Results for AI-Discovered Oncology Drug Candidate LP-184

Lantern Pharma Reports Positive Phase 1a Results for AI-Discovered Oncology Drug Candidate LP-184

Lantern Pharma has released detailed results from its completed Phase 1a dose-escalation study of LP-184, an oncology drug candidate discovered and developed using artificial intelligence. The study, ...

December 3, 2025Read More →
Maximize your thought leadership
Soligenix's HyBryte Development Highlights Dual Challenge of Rare Disease Treatment and Policy Support

Soligenix's HyBryte Development Highlights Dual Challenge of Rare Disease Treatment and Policy Support

The growing burden of rare diseases affecting more than 30 million Americans has created an urgent need for new therapies, placing companies like Soligenix Inc. at the forefront of both medical innova...

December 3, 2025Read More →
Annual Shoebox Packing Party Unites Community to Prepare Over 15,000 Gifts for Children Worldwide

Annual Shoebox Packing Party Unites Community to Prepare Over 15,000 Gifts for Children Worldwide

More than 535 Las Vegas volunteers gathered at Remnant Ministries to pack 15,519 Operation Christmas Child shoeboxes. Supported by local partners and Lion Wholesale, the event united the community in ...

December 3, 2025Read More →
Annovis Bio to Present Comprehensive Buntanetap Data at Parkinson Study Group Meeting

Annovis Bio to Present Comprehensive Buntanetap Data at Parkinson Study Group Meeting

Annovis Bio Inc. will present new data on its lead drug candidate buntanetap at the 2025 Annual Meeting of the Parkinson Study Group in San Diego. The presentation will expand on recent Phase 3 biomar...

December 3, 2025Read More →
Nature Review Highlights Urgent Cardiovascular Crisis in Dialysis Patients, Points to New Therapeutic Approach

Nature Review Highlights Urgent Cardiovascular Crisis in Dialysis Patients, Points to New Therapeutic Approach

The scientific journal Nature recently published a review article that reinforces the urgent need to address cardiovascular disease in end-stage renal disease patients. The article, titled "Still Sear...

December 3, 2025Read More →
Extend your brand profile by curating daily news.
Manhattan Jury Awards $2 Million to Hotel Guest Injured in Bathroom Fall

Manhattan Jury Awards $2 Million to Hotel Guest Injured in Bathroom Fall

A Manhattan jury has awarded $2,021,000 to a 64-year-old man who suffered severe injuries after slipping and falling on the wet marble floor of a communal bathroom at The Jane Hotel in New York City. ...

December 3, 2025Read More →
Florida CCHR Demands Total Ban on Electroconvulsive Therapy Following International Survey Revealing Widespread Harm

Florida CCHR Demands Total Ban on Electroconvulsive Therapy Following International Survey Revealing Widespread Harm

The Florida chapter of the Citizens Commission on Human Rights is intensifying its call for a total ban on electroconvulsive therapy following the release of a landmark international survey documentin...

December 3, 2025Read More →
Women Entrepreneurs Transform Personal Adversity Into Business Legacy and Purpose

Women Entrepreneurs Transform Personal Adversity Into Business Legacy and Purpose

Entrepreneur published an article exploring how three women rebuilt their lives and careers after major personal disruption, turning loss into the foundation for leadership, purpose, and legacy. The p...

December 2, 2025Read More →
Elmos Semiconductor to Unveil Vehicle Innovations at CES 2026

Elmos Semiconductor to Unveil Vehicle Innovations at CES 2026

Elmos Semiconductor SE will present its latest semiconductor innovations during CES 2026 in Las Vegas from January 6 to 9, 2026. The company will demonstrate how its technologies make vehicles smarter...

December 2, 2025Read More →
Maximize your thought leadership